Royalty Pharma CLO George Lloyd to step down; Arthur McGivern to assume role Jan 1, 2026

Royalty Pharma plc

George W. Lloyd transitions from EVP and Chief Legal Officer effective Dec 31, 2025.
Lloyd will remain employed as a senior advisor to the Company.
Arthur R. McGivern, EVP and General Counsel, assumes CLO responsibilities on Jan 1, 2026.
McGivern joined Royalty Pharma in Oct 2022 from Goodwin Procter LLP.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.